Canine Atopic Dermatitis: Chronic Itch and Welfare

Atopic dermatitis is the most common chronic skin disease in dogs, causing persistent itch, secondary infections and significant welfare compromise. Management has improved substantially.

Key Facts

Approximately 10-15% of dogs develop atopic dermatitis
West Highland White Terriers, Labradors and French Bulldogs are highest risk breeds
Affected dogs scratch, chew and rub incessantly — causing self-trauma and secondary infection
Novel biological treatments (Cytopoint) and JAK inhibitors (Apoquel) provide effective relief
Identification and management of environmental and food allergens can reduce clinical signs

Welfare Considerations

Chronic itch in atopic dogs causes significant and persistent suffering that owners may underestimate because the dog continues to function relatively normally despite constant discomfort. Secondary skin infections from self-trauma cause additional pain and require antibiotic treatment. The development of Cytopoint (monoclonal antibody) and Apoquel (JAK inhibitor) has provided safe, effective treatments that dramatically reduce itch within hours to days of administration. Welfare-positive management requires treating the itch, not just the secondary infections.

What You Can Do

Seek veterinary assessment for any dog with chronic scratching, licking or skin problems
Ask about Cytopoint or Apoquel as first-line anti-itch treatment for atopic dogs
Work with a veterinary dermatologist for allergen identification and immunotherapy
Maintain regular bathing with appropriate shampoos to reduce allergen load
Never use corticosteroids as long-term sole management — safer alternatives now exist